Introducing a minimally invasive precision drug delivery platform that enables administration of therapy to intricate brain regions for a diverse range of therapeutics in Neuro Oncology and Neurology

Time: 9:30 am
day: Conference Day One


  • Conventional delivery methods face blood-brain barrier issues, causing low efficacy and systemic side effects; surgical options are invasive, complex, with limited reach with complications.
  • Presenting a novel precision drug delivery platform that outperforms conventional methods by maximizing on-target efficacy and minimizing systemic side effects.
  • Reviewing pre-clinical safety studies comparing Bionaut motion to standard ventricular catheter insertion in large animals.